Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian population
Open Access
- 13 August 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1398411
Abstract
Background: Prostate cancer (PCa) is a leading cause of cancer-related deaths in European men, emphasizing the urgent need for effective risk assessment strategies. The TP53 gene, a tumor suppressor gene frequently mutated in cancer, commonly harbors the rs1042522 single nucleotide polymorphism (SNP), known as the P72R SNP, which may influence PCa susceptibility. This study investigated the prevalence of the P72R SNP in European Caucasian PCa samples and its association with PCa risk.Methods: Genotyping was conducted on 12 hormone-naïve aggressive PCa cultures (hnPCs) from untreated patients (Gleason ≥8), 11 radical prostatectomies (RP), and 94 serum samples using DNA Sanger sequencing and melting curve analysis. Comparative analysis utilized data from the GnomAD database’s European Caucasian non-cancer population.Results: Our results demonstrate a significantly higher frequency of the P72R SNP in PCa samples and serums compared to the general European non-cancer population. A robust and statistically significant association (p < 0.0001) between the SNP and prostate cancer risk was identified, with an odds ratio of 7.937 (95% CI 5.37-11.00). Notably, the G allele (R72) showed a pronounced prevalence in high Gleason score (≥8) patients, although statistical significance was not reached. These results highlight a potential association with undifferentiated and malignant PCa lesions.Conclusion: The compelling association between the P72R SNP and prostate cancer risk underscores the potential utility of this marker for the early identification of patients at risk of aggressive metastatic prostate cancer. This insight could empower further research to intervene at an early stage by offering enhanced opportunities for timely and targeted interventions.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Inherited TP53 Variants and Risk of Prostate CancerEuropean Urology, 2021
- Molecular Subtypes of Prostate CancerCurrent Oncology Reports, 2018
- Integrative Clinical Genomics of Advanced Prostate CancerCell, 2015
- Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysisTumor Biology, 2014
- Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinomaGene, 2013
- Analysis of Genetic Damage and Gene Polymorphism in Hepatocellular Carcinoma (HCC) Patients in a South Indian PopulationDigestive Diseases and Sciences, 2012
- Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancerEuropean Journal of Surgical Oncology, 2010
- Retention of the Arginine Allele in Codon 72 of the p53 Gene Correlates with Poor Apoptosis in Head and Neck CancerThe American Journal of Pathology, 2004
- A p53 codon 72 polymorphism associated with prostate cancer development and progression in JapaneseJournal of Biomedical Science, 2003
- Association of codon 72 polymorphism of p53 with lower prostate cancer riskThe Prostate, 2001